VMD Viemed Healthcare
Viemed Healthcare earnings company data as of 11:02 AM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | 0.12 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by VMD's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $1.6M sold by 3 insiders outside a trading plan
- None no planned (10b5-1) sales
-
William Frazier Chief Medical OfficerSale$117K 10,000 shares at $11.72 12% of stakeTraded Jun 25 Filed Jun 26
-
Timothy Smokoff DirectorSale$230K 20,000 shares at $11.50 21% of stakeTraded Jun 24 Filed Jun 26
-
Michael Moore PresidentSale$1.2M 136,802 shares at $9.05 7.9% of stakeTraded Mar 18–20 Filed Mar 20
Also filed in the last 12 months, not counted as buying or selling: 48 option exercises, 23 sales back to the company, and 20 share withholdings for taxes.
SEC filings
Recent issuer filings from EDGAR, 14 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 2.02,7.01,8.01,9.01 | Filing Doc | |
| 10-K | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.